This Genetics Stock Could Have a Bright Future

There's no doubt that the genetics industry is full of investment opportunities. In this Fool Live video clip, recorded on May 21, Fool.com contributor Brian Orelli, PhD, and healthcare bureau chief Corinne Cardina discuss why Intellia Therapeutics (NASDAQ: NTLA) should be on investors' radar. 

Continue reading

Source Fool.com